Keyphrases
Circulating Tumor DNA (ctDNA)
100%
Hepatocarcinoma
100%
Plasma Samples
50%
Treatment Response
33%
Clonality
16%
New Therapeutics
16%
Promising Biomarkers
16%
Dynamic Monitoring
16%
Cancer Cells
16%
Liver Cancer
16%
Clonal Evolution
16%
Clonal Structure
16%
Private Alleles
16%
Clinical Application
16%
Actionable Target
16%
Advanced Stage
16%
Poor Prognosis
16%
Tumor Burden
16%
Response to Therapy
16%
Disease Response
16%
Disease Progression
16%
Minor Clone
16%
Cell Clones
16%
Non-invasive Method
16%
Medicine and Dentistry
Circulating Tumor DNA
100%
Hepatocellular Carcinoma
100%
Neoplasm
33%
Biological Marker
33%
Treatment Response
33%
Cancer Cell
16%
Clonal Variation
16%
Non Invasive Procedure
16%
Prevalence
16%
Population Structure
16%
Disease Exacerbation
16%
Liver Cancer
16%
Immunology and Microbiology
Blood Plasma
100%
Dynamics
66%
Prevalence
33%
Clonal Evolution
33%
Population Structure
33%
Cell Clone
33%
Cancer Cell
33%
Tumor Volume
33%
Clonal Variation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Circulating Tumor DNA
100%
Neoplasm
33%
Biological Marker
33%
Liver Cancer
16%
Malignant Neoplasm
16%
Prevalence
16%
Disease Exacerbation
16%
Biochemistry, Genetics and Molecular Biology